865
Views
15
CrossRef citations to date
0
Altmetric
Review

Treatment of pneumonia in elderly patients

&
Pages 499-507 | Published online: 23 Mar 2006

Bibliography

  • RUIZ M, MARCOS MA, MARTINEZ JA, MENSA J, TORRES A: Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am. J. Respir. Crit. Care Med. (1999) 160:397-405.
  • MARSTON BJ, FILE TM JR, SALSTROM SJ et al.: Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch. Intern. Med (1997) 157:1709-1918.
  • JANSSENS JP, KRAUSE KH: Pneumonia in the very old. Lancet Infect. Dis. (2005) 4:112-124.
  • NIEDERMAN MS, MCCOMBS JS, KUMAR A, UNGER AN, POPOVIAN R: The cost of treating community-acquired pneumonia. Clin. Ther. (1998) 20:820-837.
  • RIQUELME R, TORRES A, EL EBIARY M et al.: Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am. J. Respir. Crit. Care Med. (1996) 154:1450-1455.
  • EL-SOLH AA, PIETRANTONI C, BHAT A, BHORA M, BERBARY E: Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia. Clin. Infect. Dis. (2004) 39:474-480.
  • KIKAWADA M, IWAMOTO T, TAKASAKI M: Aspiration and infection in the elderly: epidemiology, diagnosis and management. Drugs Aging (2005) 22:115-130.
  • CHRISTENSON B, HEDLUND J, LUNDBERG P, ORTQVIST A: Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur. Respir. J. (2004) 23:363-368.
  • JOKINEN C, HEISKANEN L, JUVONEN H et al.: Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am. J. Epidemiol. (1993) 137:977-988.
  • JACKSON ML, NEUZIL KM, THOMPSON WW et al.: The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin. Infect. Dis. (2004) 39:1642-1650.
  • MARRIE TJ: Pneumonia in the long-term-care facility. Infect. Control Hosp. Epidemiol. (2002) 23:159-164.
  • RELLO J, RODRIGUEZ R, JUBERT P, ALVAREZ B: Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. Clin. Infect. Dis. (1996) 23: 723-728.
  • EL-SOLH AA, SIKKA P, RAMADAN F, DAVIES J: Etiology of severe pneumonia in the very elderly. Am. J. Respir. Crit. Care Med. (2001) 163:645-651.
  • KAPLAN V, CLERMONT G, GRIFFIN MF et al.: Pneumonia: still the old man’s friend? Arch. Intern. Med. (2003) 163:317-323.
  • KOIVULAI, STEN M, MAKELA PH: Risk factors for pneumonia in the elderly. Am. J. Med. (1994) 96:313-320.
  • LOEB M, MCGEER A, MCARTHUR M, WALTER S, SIMON AE: Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch. Intern. Med. (1999) 159:2058-2064.
  • ZALACAIN R, TORRES A, CELIS R et al.: Community-acquired pneumonia in the elderly: Spanish multicentre study. Eur. Respir. J. (2003) 21:294-302.
  • JOKINEN C, HEISKANEN L, JUVONEN H et al.: Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin. Infect. Dis. (2001) 32:1141-1154.
  • GLEZEN WP, GREENBERG SB, ATMAR RL, PIEDRA PA, COUCH RB: Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA (2000) 283:499-505.
  • TROY CJ, PEELING RW, ELLIS AG et al.: Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA (1997) 277:1214-1218.
  • LIM WS, MACFARLANE JT: A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur. Respir. J. (2001) 18:362-368.
  • BRITISH THORACIC SOCIETY STANDARDS OF CARE COMMITTEE: BTS Guidelines for the management of community acquired pneumonia in adults. Thorax (2001) 56:1-64.
  • NIEDERMAN MS, MANDELL LA, ANZUETO A et al.: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med. (2001) 163:1730-1754.
  • MARIK PE: Aspiration pneumonitis and aspiration pneumonia. N. Engl. J. Med. (2001) 344:665-671.
  • BARTLETT JC, GORBACH SL, FINEGOLD SM: The bacteriology of aspiration pneumonia. Am. J. Med. (1974) 56:202-207.
  • ALLEWEL TM, SCHULER P, BOLCSKEI PL, MAUCH H, LODE H, STUDY GROUP ON ASPIRATION PNEUMONIA: Ampicillin + sulbactam versus clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin. Microbiol. Infect. (2004) 10:163-170.
  • RIQUELME R, TORRES A, EL EBIARY M, MENSA J, ESTRUCH R, RUIZ M, ANGRILL J, SOLER N: Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am. J. Respir. Crit. Care Med. (1997) 156:1908-1914.
  • METLAY JP, SCHULZ R, LI YH et al.: Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch. Intern. Med. (1997) 157:1453-1459.
  • BASI SK, MARRIE TJ, HUANG JQ, MAJUMDAR SR: Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcomes. Am. J. Med. (2004) 117:305-311.
  • MARRIE TJ, HUANG JQ: Epidemiology of community-acquired pneumonia in Edmonton, Alberta: an emergency department-based study. Can. Respir. J. (2005) 12:139-142.
  • MYLOTTE JM, GOODNOUGH S, NAUGHTON BJ: Pneumonia versus aspiration pneumonitis in nursing home residents: diagnosis and management. J. Am. Geriatr. Soc. (2003) 51:17-23.
  • MARIK PE, KAPLAN D: Aspiration pneumonia and dysphagia in the elderly. Chest (2003) 124:328-336.
  • KIKUCHI R, WATABE N, KONNO T, MISHINA N, SEKIZAWA K, SASAKI H: High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. (1994) 150:251-253.
  • TERPENNING M: Geriatric oral health and pneumonia risk. Clin. Infect. Dis. (2005) 40:1807-1810.
  • FINE MJ, AUBLE TE, YEALY DM et al.: A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. (1997) 336:243-250.
  • LIM WS, VAN DER EERDEN MM, LAING R et al.: Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax (2003) 58:377-382.
  • EWIG S, KLEINFELD T, BAUER T, SEIFERT K, SCHAFER H, GOKE N: Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population. Eur. Respir. J. (1999) 14:370-375.
  • MARRIE TJ, LAU CY, WHEELER SL, WONG CJ, FEAGAN BG: Predictors of symptom resolution in patients with community-acquired pneumonia. Clin. Infect. Dis. (2000) 31:1362-1367.
  • ELSOLH AA, AQUILINA AT, GUNEN H, RAMADAN F: Radiographic resolution of community-acquired bacterial pneumonia in the elderly. J. Am. Geriatr. Soc. (2004) 52:224-229.
  • CONTE HA, CHEN YT, MEHAL W, SCINTO JD, QUAGLIARELLO VJ: A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am. J. Med. (1999) 106:20-28.
  • MEHR DR, FOXMAN B, COLOMBO P: Risk factors for mortality from lower respiratory infections in nursing home patients. J. Fam. Pract. (1992) 34:585-591.
  • MANDELLLA, BARTLETT JC, DOWELL SF et al.: Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin. Infect. Dis. (2003) 37:1405-1433.
  • BALAGUERAH U, MIR J, CRAVEN DE: Nosocomial or healthcare facility-related pneumonia in adults. Curr. Infect. Dis. Rep. (2000) 2:215-223.
  • GLEASON PP, MEEHAN TP, FINE JM, GALUSHA DH, FINE MJ: Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch. Intern. Med. (1999) 159:2562-2572.
  • GARCIA VASQUEZ E, MENSA J, MARTINEZ JA et al.: Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone. Eur. J. Clin. Microbiol. Infect. Dis. (2005) 24:190-195.
  • MEEHAN TP, FINE MJ, KRUMHOLZ HM et al.: Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA (1997) 278:2080-2084.
  • DRAKULOVIC MB, TORRES A, BAUER TT, NICOLAS JM, NOGUE S, FERRER M: Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet (1999) 354:1851-1858.
  • GILLICK MR: Rethinking the role of tube feeding in patients with advanced dementia. N. Engl. J. Med. (2000) 342:206-210.
  • NAKAJOH K, NAKAGAWA T, SEKIZAWA K, MATSUI T, ARAI H, SASAKI H: Relation between incidence of pneumonia and protective reflexes in post-stroke patients with oral or tube feeding. J. Intern. Med. (2000) 247:39-42.
  • MARIK PE, ZALOGA GP: Gastric versus post-pyloric feeding: a systematic review. Crit. Care (2003) 7:R46-R51.
  • YONEYAMA T, YOSHIDA M, OHRUI T et al.: Oral care reduces pneumonia in older patients in nursing homes. J. Am. Geriatr. Soc. (2002) 50:430-433.
  • HEDLUND J, HANSSON LO, ORTQVIST A: Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors. Scand. J. Infect. Dis. (1995) 27:32-37.
  • NICHOL KL, NORDIN J, MULLOOLY J, LASK R, FILLBRANDT K, IWANE M: Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N. Engl. J. Med. (2003) 348:1322-1332.
  • RUFBR, COLBERG K, FRICK M, PREUSCHE A: Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly. Infection (2004) 32:191-198.
  • NICHOL KL, MARGOLIS KL, WUORENMA J, VON STERNBERG T: The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. (1994) 331:778-784.
  • NORDIN J, MULLOOLY J, POBLETE S et al.: Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J. Infect. Dis. (2001) 184:665-670.
  • VOORDOUW AC, STURKENBOOM MC, DIELEMAN JP et al.: Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA (2004) 292:2089-2095.
  • RUBINS JB, ALTER M, LOCH J, JANOFF EN: Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination. Infect. Immun. (1999) 67:5979-5984.
  • WHITNEY CG, FARLEY MM, HADLER J et al.: Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. (2003) 348:1737-1746.
  • JACKSON LA, NEUZIL KM, YU O et al.: Effectiveness of pneumococcal polysaccharide vaccine in older adults. N. Engl. J. Med. (2003) 348:1755.
  • STEPHENS DS, ZUGHAIER SM, WHITNEY CG et al.: Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet (2005) 365:855-863.
  • TORLING J, HEDLUND J, KONRADSEN HB, ORTQVIST A: Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia. Vaccine (2003) 22:96-103.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.